Dergiler / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 2

Modifications of mice gut microflora following oral consumption of Lactobacillus acidophilus and Bifidobacterium bifidum probiotics

Sayfa
689–694
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Our results revealed that, unlike B. bifidum, the amount of L. acidophilus remained almost unchanged in the long term, indicating more stability of L. acidophilus than B. bifidum in the gut microflora.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Thirty male BALB/c mice were equally divided into three groups: control, L. acidophilus, and B. bifidum for the assessment of the probiotics stability in the gut microflora.
📊
Temel Bulgular & Veri:Materials and methods: First, the gut microflora of the mice was checked every 3 days (days 3, 6, 9, and 12) without probiotic consumption, and then the mice were daily given orally 1.5 g of probiotics in 30 cc of drinking water.
💡
Sonuç & Katkı:Conclusion: Our results revealed that, unlike B. bifidum, the amount of L. acidophilus remained almost unchanged in the long term, indicating more stability of L. acidophilus than B. bifidum in the gut microflora.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Thirty male BALB/c mice were equally divided into three groups: control, L. acidophilus, and B. bifidum for the assessment of the probiotics stability in the gut microflora. Materials and methods: First, the gut microflora of the mice was checked every 3 days (days 3, 6, 9, and 12) without probiotic consumption, and then the mice were daily given orally 1.5 g of probiotics in 30 cc of drinking water. The consumption of probiotics was then stopped for recovery and then the consumption continued for 5 months. Results: On day 9 after the consumption of the probiotics, L. acidophilus and B. bifidum were significantly increased from 4% to 83% and from 1% to 61%, respectively. L. acidophilus count showed no significant decrease at the end of 5 months compared to day 9 of probiotic consumption (74%), but B. bifidum count was dramatically decreased to 45% and 36% at the end of 1 and 5months, respectively. Conclusion: Our results revealed that, unlike B. bifidum, the amount of L. acidophilus remained almost unchanged in the long term, indicating more stability of L. acidophilus than B. bifidum in the gut microflora.

🔖

Bu Makaleye Atıf Yap

RAHIMI, E., KHAVARI-DANESHVAR, H., MOSAVI, M., KHODAYARI, H., RANJI, P., MOHSENI, A. H., MAHMUDIAN, R., SHIDFAR, F., AGAH, S., ALIZADEH, A. M. (2022). Modifications of mice gut microflora following oral consumption of Lactobacillus acidophilus and Bifidobacterium bifidum probiotics. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 2, 689–694. https://ajindex.com/articles/610973

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000; 78: 80-88
  2. Knight DJ, Girling KJ. Gut flora in health and disease. Lancet 2003; 361: 1831
  3. O’Mahony L, Feeney M, O’Halloran S, Murphy L, Kiely B, Fitzgibbon J, Lee G, O’Sullivan G, Shanahan F, Collins JK. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 2001; 15: 1219-1225
  4. Davis CD, Milner JA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 2009; 20: 743-752
  5. Alizadeh AM, Afrouzan H, Dinparast-Djadid N, Sawaya AC, Azizian S, Hemmati HR, Mohagheghi MA, Erfani S. Chemoprotection of MNNG-initiated gastric cancer in rats using Iranian propolis. Arch Iran Med 2015; 18: 18-23
  6. Alizadeh AM, Khaniki M, Azizian S, Mohaghgheghi MA, Sadeghizadeh M, Najafi F. Chemoprevention of azoxymethaneinitiated colon cancer in rat by using a novel polymeric nanocarrier—curcumin. Eur J Pharmacol 2012; 689: 226-232
  7. Abreu MT, Peek RM Jr. Gastrointestinal malignancy and the microbiome. Gastroenterology 2014; 146: 1534-1546
  8. Tannock GW. Medical importance of the normal microflora. Shock 2000; 13: 252
  9. Corthésy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr 2007; 137: 781S-790S
  10. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519
  11. Gopal PK, Prasad J, Gill HS. Effects of the consumption of Bifidobacterium lactis HN019 (DR10TM) and galactooligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutr Res 2003; 23: 1313-1328
  12. Rogosa M, Sharpe ME. An approach to the classification of the lactobacilli. J Appl Bacteriol 1960; 22: 329-340
  13. Amin M, Sheikh AF, Goodarzi H, Sormeh M. Identification of Bifidobacterium animalis, Bifidobacterium adolescentis and Bifidobacterium bifidum from stool of children and detection of their antibacterial properties. Adv Infect Dise 2013; 3: 200
  14. Ali FH, Ashour ZA, Shahin RY, Zaki WK, Ragab SB, Attia MY. Role of intestinal microflora (Lactobacillus acidophilus) in phagocytic function of leukocytes in type 2 diabetic patients. Egypt J Med Hum Genet 2013; 14: 95-101
  15. Leke A, Romond M, Mullie C. Insights in the human bifidobacterial flora through culture-dependent and independent techniques. Comm Curr Res Educ Top Tre